Printedbycongjiaon7/22/20197:46:55AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright''2019NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved. NCCN指南索引 NCCN指南2019年第3版 目录 讨论 毛细胞白血病
61.SavenA,BurianC,AdusumalliJ,KoziolJA.Filgrastimfor cladribine-inducedneutropenicfeverinpatientswithhairycellleukemia. Blood1999;93:2471-2477.Availableat: https://www.ncbi.nlm.nih.gov/pubmed/10194424. 62.DiBisceglieAM,LokAS,MartinP,etal.RecentUSFoodandDrug AdministrationwarningsonhepatitisBreactivationwith immune-suppressingandanticancerdrugs:justthetipoftheiceberg? Hepatology2015;61:703-711.Availableat: https://www.ncbi.nlm.nih.gov/pubmed/25412906. 63.HuangH,LiX,ZhuJ,etal.Entecavirvslamivudineforpreventionof hepatitisBvirusreactivationamongpatientswithuntreateddiffuselarge B-celllymphomareceivingR-CHOPchemotherapy:arandomizedclinical trial.JAMA2014;312:2521-2530.Availableat: https://www.ncbi.nlm.nih.gov/pubmed/25514302.
- MS11 ?? 2019年第3版,2019年1月31日?美国国家综合癌症网络公司(NCCN)2019年,保留所有权利。未得到NCCN明确书面许可,不得以任何形式对本NCCNGuidelines?(NCCN指南)及其插图进行复制。 |
|